Brian Jonas, MD, Discusses FDA Approval of Venclexta® in Combination for the Treatment of Newly Diagnosed AML

2020-11-25T14:58:26+00:00November 20th, 2020|Acute Myeloid Leukemia Condition Center, Hematology & Oncology, POCN Hem/Onc|